|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Washington Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing WashingtonLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Metheor Therapeutics Corp
| | | Phone: | (206) 228-3487 | Year Established: | 2010 | Employees: | 3 | Main Contact: | Andrew Sledziewski, CEO | | Company Description | Metheor is an early stage biotechnology company focused on discovering and developing inhibitory compounds targeting the DNA methyltransferase (DNMT) enzyme family. Their powerful proprietary platform combines molecular modeling, medicinal chemistry and biological validation systems. The company is managed by the founders, and guided by an experienced board of directors. Funding to date has been provided through two rounds from an angel group. Operations are semi-virtual: while
molecular modeling and medicinal chemistry services are provided through close academic collaborations managed by the founders, Metheor is incubating a small molecular / cell biology laboratory locally to screen the compounds and validate their activity. | |
|
|
|
|
|